Safety and efficacy of tranexamic acid in bleeding paediatric trauma patients: A systematic review protocol

BMJ Open

Volumn 6, Issue 9, 2016, Pages

  Urban, Denisa ^a   Dehaeck, Ruben ^a   Lorenzetti, Diane ^a,b,c   Guilfoyle, Jonathan ^a   Poon, Man Chiu ^a   Steele, MacGregor ^a   Lardner, David ^a   Ma, Irene Wai Yan ^a   Brindle, Mary Elizabeth ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

BLEEDING; CHILDHOOD INJURY; CINAHL; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); COCHRANE LIBRARY; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

EID: 84988938085     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-012947     Document Type: Review

References (36)

1. Murray CJL, Lopez AD, World Health Organization, et al. The Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Geneva: World Health Organization, 1996.
2. World Health Organization. The global burden of disease: 2004 update. Geneva: World Health Organization, 2008.
3. World Health Organization. Department of Injuries and Violence Prevention. The injury chart book: a graphical overview of the global burden of injuries. Geneva: World Health Organization, 2002.
4. Haagsma JA, Graetz N, Bolliger I, et al. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev 2016;22:3-18.
5. Prevention CfDCa. Leading Causes of Death Reports, National and Regional, 1999-2014. 2014. http://webappa.cdc.gov/cgi-bin/broker. exe (accessed 26 Apr 2016).
6. Peden M, World Health Organization. World report on child injury prevention. Geneva: World Health Organization, 2008.
7. Soni A. Top five most costly conditions among children, ages 0-17, 2012: estimates for the U.S. civilian noninstitutionalized population. 2015. http://meps.ahrq.gov/mepsweb/data-files/publications/st472/stat472.pdf (accessed 26 Apr 2016).
8. Beno S, Ackery AD, Callum J, et al. Tranexamic acid in pediatric trauma: why not? Crit Care 2014;18:313.
9. Moore FA, McKinley BA, Moore EE. The next generation in shock resuscitation. Lancet 2004;363:1988-96.
10. Schenone M, Furie BC, Furie B. The blood coagulation cascade. Curr Opin Hematol 2004;11:272-7.
11. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008;64:1211-17; discussion 17.
12. Davenport R. Pathogenesis of acute traumatic coagulopathy. Transfusion 2013;53(Suppl 1):23S-7S.
13. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma 2003;54:1127-30.
14. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39-44.
15. Maegele M, Schöchl H, Cohen MJ. An update on the coagulopathy of trauma. Shock 2014;41(Suppl 1):21-5.
16. Cap A, Hunt B. Acute traumatic coagulopathy. Curr Opin Crit Care 2014;20:638-45.
17. Dzik WH, Blajchman MA, Fergusson D, et al. Clinical review: Canadian National Advisory Committee on Blood and Blood Products-massive transfusion consensus conference 2011: report of the panel. Crit Care 2011;15:242.
18. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl 1987;137:22-5.
19. Williams-Johnson JA, McDonald AH, Strachan GG, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. West Indian Med J 2010;59:612-24.
20. Roberts I, Shakur H, Afolabi A, et al. CRASH-2 Collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011;377:1096-101, 101 e1-2.
21. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg 2012;147:113-19.
22. Morrison JJ, Ross JD, Dubose JJ, et al. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II study. JAMA Surg 2013;148:218-25.
23. Schouten ES, van de Pol AC, Schouten AN, et al. The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: a meta-analysis. Pediatr Crit Care Med 2009;10:182-90.
24. Grant JA, Howard J, Luntley J, et al. Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid. J Pediatr Orthop 2009;29:300-4.
25. Faraoni D, Goobie SM. The efficacy of antifibrinolytic drugs in children undergoing noncardiac surgery: a systematic review of the literature. Anesth Analg 2014;118:628-36.
26. Faraoni D, Willems A, Melot C, et al. Efficacy of tranexamic acid in paediatric cardiac surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg 2012;42:781-6.
27. Sessler DI. New surgical thermal management guidelines. Lancet 2009;374:1049-50.
28. Carless PA, Henry DA, Moxey AJ, et alCell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006;(4):CD001888.
29. Dobson GP, Letson HL, Sharma R, et al. Mechanisms of early trauma-induced coagulopathy: the clot thickens or not? J Trauma Acute Care Surg 2015;79:301-9.
30. Eckert MJ, Wertin TM, Tyner SD, et al. Tranexamic acid administration to pediatric trauma patients in a combat setting: the pediatric trauma and tranexamic acid study (PED-TRAX). J Trauma Acute Care Surg 2014;77:852-8; discussion 58.
31. Royal College of Paediatrics and Child Health. Evidence Statement: major trauma and the use of tranexamic acid in children, November 2012. 2012. https://www.tarn.ac.uk/content/downloads/3100/121112-TXA evidence statement-final v2.pdf (accessed 26 Jan 2016).
32. The Alberta Children's Hospital. Massive Transfusion Protocol. 2009. http://iweb.calgaryhealthregion.ca/programs/trauma/pdf/mtp-oct2009.pdf (accessed 26 Jan 2016).
33. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library, 2008.
34. McGinn T, Wyer PC, Newman TB, et al. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004;171:1369-73.
35. Cooper H, Hedges LV, Valentine JC. The handbook of research synthesis and meta-analysis. Russell Sage Foundation, 2009.
36. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.